𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A french national epidemiologic survey on renal cell carcinoma

✍ Scribed by D. Bretheau; A. Koutani; E. Lechevallier; C. Coulange


Publisher
John Wiley and Sons
Year
1998
Tongue
English
Weight
146 KB
Volume
82
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Background:

In this multicenter study, the yearly national evaluation of tumors of the kidney was out by the oncology committee of the french association of urology.

Methods:

During the period from april 1, 1992, to march 31, 1994, 1486 patients from 54 centers were included in this study. for each patient, an individual chart was created, in which age, gender, discovery circumstances of the tumor, radiologic and biologic workup, treatment, tnm classification, and histologic features of the tumor were recorded.

Results:

The mean patient age was 62.1 years, and the male-to-female ratio was 2:1. forty percent of the tumors were discovered accidentally. a radical nephrectomy was performed in 93% of the cases, and in 7% of the cases, conservative management was adopted. medical treatment was chosen in 5% of the cases. the patient distribution according to classification was as follows: pt1 = 8%, pt2 = 53%, pt3a = 21%, and pt3b = 18%. lymph node involvement was observed in 9% and visceral metastasis in 6% of the cases. the incidental tumors were intracapsular in 80% of the cases. from the histologic point of view, the majority of the tumors were clear cell adenocarcinoma (66%). the mean tumor maximum dimension was 6.4 +/- 3.5 cm; it was significantly greater in symptomatic patients and patients with poor prognostic indicators (involvement of the adrenal gland, inferior vena cava, and/or lymph nodes and visceral metastasis). adrenal gland involvement or inferior vena cava involvement were each observed in 4% of the cases. fourteen percent of the patients had multicentric tumor spread, which was influenced by neither the tumor size nor the cell type. the nuclear grade was established in 66% of the cases and was significantly correlated with involvement of the perirenal fat and the lymph nodes.

Conclusions:

This study allowed the authors to centralize one-fifth of all new cases of adenocarcinoma of the kidney in france in the course of a year. it enabled them to evaluate precisely the current epidemiologic profile of this disease among those patients.


📜 SIMILAR VOLUMES


Chemotherapy for breast carcinoma during
✍ Pierre-Ludovic Giacalone; Francois Laffargue; Paul Bénos 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

The authors wish to thank all the members of the "Socie ´te ´Franc ¸aise d'Oncologie Gyne ´cologique and the Socie ´te ´Franc ¸aise de Se ´nologie et de Pathologie Mammaire" for their collaboration.

Risk factors for renal-cell carcinoma in
✍ Simone Benhamou; Marie-Hélène Lenfant; Catherine Ory-Paoletti; Robert Flamant 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 583 KB

A hospital-based case-control study of renal-cell carcinoma was conducted in France from 1987 to 1991. A total of 196 histologically confirmed cases (I38 males and 58 females) and 347 controls (235 males and I I 2 females), matched for sex, age at interview, hospital and interviewer, were included.

ESTIMATING MEANS AND PERCENTAGES IN A CO
✍ JOSIANE WARSZAWSKI; ANTOINE MESSIAH; JOSEPH LELLOUCH; LAURENCE MEYER; JEAN-CLAUD 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 520 KB

Two-phase stratification sampling with unequal selection probabilities is a relatively cost-efficient strategy to address problems on a nationwide basis and to perform comparative analyses of specific subgroups. This was the case with the ACSF survey. Specific procedures to estimate the variances of

A national French survey on the use of g
✍ Thierry Thévenot; Jean-François Cadranel; Vincent Di Martino; Alexandre Pariente 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

We conducted a national retrospective survey on hospital practitioners to evaluate the magnitude of erythropoietin (EPO) or granulocyte colony-stimulating factor (G-CSF) prescriptions in patients treated for chronic hepatitis C. Four hundred seventy-one questionnaires were sent, and 274 practitioner